Clinical Characteristics and Therapeutic Results of 350 Elderly Patients With Aggressive-Histology NHL
| Age (yr) | |
| Median | 69 |
| Range | 60-87 |
| Sex (male/female) | 174/176 |
| Symptoms (no/yes) | 238/112 |
| Stage | |
| II | 123 (35%) |
| III | 79 (23%) |
| IV | 148 (42%) |
| Bulky disease | 98 (28%) |
| LDH (>normal) | 123 (35%) |
| Bone marrow involvement | 64 (18%) |
| Extranodal sites (no/yes) | 207/143 |
| Histology | |
| Centroblastic | 182 (52%) |
| Immunoblastic | 98 (28%) |
| Anaplastic large cell | 21 (6%) |
| Peripheral T cell | 49 (14%) |
| Result | |
| CR | 202 (58%) |
| PR | 87 (25%) |
| NR | 61 (17%) |
| Age (yr) | |
| Median | 69 |
| Range | 60-87 |
| Sex (male/female) | 174/176 |
| Symptoms (no/yes) | 238/112 |
| Stage | |
| II | 123 (35%) |
| III | 79 (23%) |
| IV | 148 (42%) |
| Bulky disease | 98 (28%) |
| LDH (>normal) | 123 (35%) |
| Bone marrow involvement | 64 (18%) |
| Extranodal sites (no/yes) | 207/143 |
| Histology | |
| Centroblastic | 182 (52%) |
| Immunoblastic | 98 (28%) |
| Anaplastic large cell | 21 (6%) |
| Peripheral T cell | 49 (14%) |
| Result | |
| CR | 202 (58%) |
| PR | 87 (25%) |
| NR | 61 (17%) |